Clinical Trial: A Study on the Efficacy and Safety of Fecal Microbiota Transplantation-Based Therapy for Alcoholic Liver Disease and Intervention in Alcohol Relapse (China)

China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy and Safety of Fecal Microbiota Transplantation-Based Therapy for Alcoholic Liver Disease and Intervention in Alcohol Relapse'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135118

Registration Time: 2026/10/26

Type: Interventional study

Primary Sponsor: Beijing Huilongguan Hospital, Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344100

Published by HT Digital Content Services with permission from Health Daily Digest....